Tilray Brands, Inc. splits its revenue into 5 lines in its filings. The largest line in fiscal 2026, which ended May 31, 2026 was Cannabis at $352.3 million, 38% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2027
Aug 31, 2026
|
FY 2026
May 31, 2026
|
FY 2025
May 31, 2025
|
FY 2024
May 31, 2024
|
FY 2023
May 31, 2023
|
FY 2022
May 31, 2022
|
FY 2021
May 31, 2021
|
FY 2020
Dec 31, 2020
|
FY 2019
Dec 31, 2019
|
FY 2018
Dec 31, 2018
|
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
963
|
915
|
821
|
789
|
627
|
628
|
513
|
210
|
167
|
43
|
| Cannabis |
340
+0.8%
share 35.3%
|
352
+6.6%
share 38.5%
|
331
-10.8%
share 40.3%
|
371
+30.4%
share 47.0%
|
284
-5.5%
share 45.3%
|
301
+49.4%
share 47.9%
|
201
share 39.3%
|
—
|
—
|
—
|
| Distribution Business |
338
+21.8%
share 35.0%
|
327
+20.7%
share 35.7%
|
271
+4.8%
share 33.0%
|
259
-0.0%
share 32.8%
|
259
-0.4%
share 41.3%
|
260
share 41.3%
|
—
|
—
|
—
|
—
|
| Beverage Alcohol Business |
311
+23.2%
share 32.3%
|
265
+4.8%
share 29.0%
|
253
+18.5%
share 30.8%
|
214
+112.2%
share 27.1%
|
101
+34.3%
share 16.1%
|
75
share 11.9%
|
—
|
—
|
—
|
—
|
| Tilray Pharma |
—
|
—
|
—
|
—
|
—
|
260
-6.3%
share 41.3%
|
277
share 54.0%
|
—
|
—
|
—
|
| Beverage Alcohol |
—
|
—
|
—
|
—
|
—
|
71
+150.0%
share 11.4%
|
29
share 5.6%
|
—
|
—
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- TLRY (Nasdaq)
- Fiscal year ends
- May 31
- Headquarters
- New York, NY
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1731348
- Former names
- Tilray, Inc. (until Jan 10, 2022)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- SNDL Inc. SNDL
- Aurora Cannabis Inc ACB
Source: SEC EDGAR filings. This is company-reported data, not investment advice.